Continuous plasma resin perfusion for detoxification of methotrexate

Eur J Pediatr. 1997 Jul;156(7):533-6. doi: 10.1007/s004310050656.

Abstract

Acute renal failure is a rare but very severe side-effect of methotrexate (MTX) treatment requiring extracorporeal detoxification. A new detoxification regime, consisting of a haemodiafiltration (HDF) and continuous plasma resin perfusion (PRP) over anion exchange resin column with high affinity for MTX, was used for treatment of MTX-induced acute renal failure in a 2-year-old boy with medulloblastoma. More than 99% of MTX was removed from plasma by perfusion over the resin column resulting in a marked decrease of MTX plasma half-life. No haematological complications occurred.

Conclusion: The use of PRP alone or in combination with HDF is a new and effective treatment strategy for extracorporeal detoxification of MTX.

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury / chemically induced*
  • Acute Kidney Injury / therapy
  • Antimetabolites, Antineoplastic / adverse effects*
  • Antimetabolites, Antineoplastic / pharmacokinetics
  • Child, Preschool
  • Hemodiafiltration
  • Humans
  • Ion Exchange Resins
  • Male
  • Metabolic Clearance Rate
  • Methotrexate / adverse effects*
  • Methotrexate / pharmacokinetics
  • Sorption Detoxification / methods*

Substances

  • Antimetabolites, Antineoplastic
  • Ion Exchange Resins
  • Methotrexate